Coromoto Palermo-Garófalo, José Hernán Martínez, Frieda Silva, Eva González, Oberto Torres, Jannette Figueroa, José González, Miranda María de Lourdes
Internal Medicine and Endocrinology Department, San Juan City Hospital, San Juan Puerto Rico. coropalermo@caribe.net
Boletín de la Asociación Médica de Puerto Rico 2013Amiodarone is used in a large number of cardiac conditions. Amiodarone-induced thyroid dysfunction has been reported to affect up to 20% of users. Amiodarone can lead to both amiodarone-induced hypothyroidism (AIH) and less commonly amiodarone-induced thyrotoxicosis (AIT). There are two main forms of AIT. Type 1 AIT, a form of io-dine-induced hyperthyroidism, and type 2, a drug-induced destructive thyroiditis. Type 1 AIT develops on individuals with underlying thyroid disease. Treatment of Type 1 AIT includes the use of antithyroid drugs and discontinuation of amiodarone. Type 2 AIT is commonly self-limiting in nature. In this article wedescribe a patient with Amiodarone-induced thyrotoxicosis discussing its clinical features and medical therapeutic approach.
Coromoto Palermo-Garófalo, José Hernán Martínez, Frieda Silva, Eva González, Oberto Torres, Jannette Figueroa, José González, Miranda María de Lourdes. The cardiology and endocrinology connection between amiodarone and thyrotoxicosis: case report and review of the literature. Boletín de la Asociación Médica de Puerto Rico. 2013;105(2):47-53
PMID: 23882990
View Full Text